Clinical Application Strategies of Maxillary Sinus Buccal Bony Window
1 other identifier
interventional
60
1 country
1
Brief Summary
Through randomized controlled trials, investigators will recruit participants who need maxillary sinus floor elevation with different residual bone height, and utilize the maxillary sinus buccal bony window during the surgery. Then investigators will gather the related information of participants, collect and analyze their CBCT data, in order to help surgeons select the best operating method for different patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 10, 2022
CompletedFirst Submitted
Initial submission to the registry
March 12, 2022
CompletedFirst Posted
Study publicly available on registry
April 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 2, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2032
ExpectedApril 7, 2022
March 1, 2022
12 months
March 12, 2022
March 30, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
ABH change
Apical bone height (ABH): Represented the grafted height at baseline and the grafted height with neo-formed bone at follow-ups.
baseline, 6 months, and 1, 2, 3, 5, 10 years after the surgery
ESBG change
Endo-sinus bone gain (ESBG): ESBG = ABH + implant protrusion length at baseline; ESBG represented the grafted height and neo-formed bone, and described the height difference of radiopaque area in the sinus cavity at different times.
baseline, 6 months, and 1, 2, 3, 5, 10 years after the surgery
RBH
Residual bone height (RBH): Only assessed at baseline
baseline
Study Arms (6)
a: ground into pieces
EXPERIMENTAL0\~3mm
b: replace the bone
EXPERIMENTAL0\~3mm
c: turn inward
EXPERIMENTAL0\~3mm
d: ground into pieces
EXPERIMENTAL3\~5mm
e: replace the bone
EXPERIMENTAL3\~5mm
f: turn inward
EXPERIMENTAL3\~5mm
Interventions
a: 0\~3mm+ground into pieces; b: 0\~3mm+replace the bone; c: 0\~3mm+turn inward to hold up the membrane; d: 3\~5mm+ground into pieces; e: 3\~5mm+replace the bone; f: 3\~5mm+turn inward to hold up the membrane
Eligibility Criteria
You may qualify if:
- A single maxillary posterior tooth was missing, and the missing time was ≥ 3 months
- Gingival distance ≥ 4mm
- Residual bone height ≤ 5mm and residual bone width ≥ 6mm
- Good systemic health
- CBCT image was complete and clear, and there was no obvious artifact affecting the measurement
- Informed consent.
You may not qualify if:
- Untreated diabetes or other serious systemic diseases
- Untreated periodontal disease
- Uncontrolled periapical lesions of adjacent teeth
- Certain bone diseases such as osteoporosis and osteosclerosis
- Severe night bruxism
- Mental illness
- Pregnant or breast-feeding patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Affiliated Hospital of Stomatology, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Related Publications (3)
Starch-Jensen T, Jensen JD. Maxillary Sinus Floor Augmentation: a Review of Selected Treatment Modalities. J Oral Maxillofac Res. 2017 Sep 30;8(3):e3. doi: 10.5037/jomr.2017.8303. eCollection 2017 Jul-Sep.
PMID: 29142655RESULTNiu L, Wang J, Yu H, Qiu L. New classification of maxillary sinus contours and its relation to sinus floor elevation surgery. Clin Implant Dent Relat Res. 2018 Aug;20(4):493-500. doi: 10.1111/cid.12606. Epub 2018 Apr 25.
PMID: 29691967RESULTZhou Y, Shi Y, Si M, Wu M, Xie Z. The comparative evaluation of transcrestal and lateral sinus floor elevation in sites with residual bone height </=6 mm: A two-year prospective randomized study. Clin Oral Implants Res. 2021 Feb;32(2):180-191. doi: 10.1111/clr.13688. Epub 2020 Dec 26.
PMID: 33220090RESULT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
March 12, 2022
First Posted
April 7, 2022
Study Start
March 10, 2022
Primary Completion
March 2, 2023
Study Completion (Estimated)
December 31, 2032
Last Updated
April 7, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share